Validation and qualification, reinvented
We don't run validation the way it has always been run. We combine artificial intelligence, process automation and data analytics with regulatory good practice — delivering defensible evidence in a fraction of the time, with qualified review exactly where the standard demands it.
Three technologies that change the cost and timeline of validation
Traditional consultancies scale by hiring people. We scale with technology — and keep the regulatory decision where it belongs: with a qualified reviewer.
Assisted documentation, not automatic
AI drafts URS, risk assessments, specifications, protocols and reports from a single knowledge base. Every output records tool, version, input, reviewer and approval — the control the draft EU GMP Annex 22 will require.
Evidence capture without typing
Robots walk the system screens, capture configuration, audit trail and access profiles, and assemble the paginated dossier. What used to take weeks of manual screenshots now runs on its own, with the path itself recorded.
Review by exception, not by sampling
The full audit trail analysed for anomalies instead of a sample. Validated-state indicators, deviation detection and risk prioritisation driven by data rather than impression.
None of this replaces regulatory judgement. It replaces the repetitive work that consumes the time of the people who should be exercising it.
What we do
Six fronts covering the lifecycle of systems, infrastructure, processes and data in GxP environments.
Computerized System Validation
From validation plan to final report, with a risk-based approach and CSA.
IT & OT Infrastructure Qualification
Servers, networks, cloud, SCADA and PLCs qualified on a "qualify once, deploy many" model.
Commissioning, Qualification & Validation
Qualification of production equipment and processes with DQ, IQ, OQ and PQ, integrated with commissioning.
Data Integrity
ALCOA+ gap assessment, remediation and audit-trail governance across the GxP lifecycle.
GMP Audits & Compliance
Internal and supplier audits and mock inspections to arrive ready for inspections.
Training
Hands-on training in GAMP 5, CSV, Data Integrity and GMP, in-company or remote.
Artificial Intelligence Governance
Inventory, usage policy and output traceability for AI in GxP processes.
The validation lifecycle, automated where it can be and reviewed where it must be
AI drafts and traces. The qualified reviewer decides and signs. No critical step leaves human hands — that is how the schedule gain survives an inspection.
System technical documentation, key-user interviews, screens and release notes.
Every node records tool, version, input, reviewer and approval. It is the same control the draft EU GMP Annex 22 will expect of your operation.
What changes in your case
A parametric model with open assumptions. Move the controls and see the effect on documentation effort. Not a quote and not measured client data — it is the model we use to size scope.
- AI cuts drafting by 70%. Qualified review and test execution are not reduced.
- Specification documents are 75% drafting. IQ/OQ/PQ protocols are 35% drafting and 65% execution.
- Assumed capacity: 30 productive hours per week per senior consultant.
- GAMP category multiplies base effort: C3 ×1.0 · C4 ×1.6 · C5 ×2.4.
Illustrative figures derived from the assumptions above. Real scope is sized in the assessment.
The V-cycle, no loose ends
Every specification on the left has a mirrored verification on the right, linked by a living traceability matrix — from URS to validation report.
Risk-based
Effort proportional to GxP impact. No excess documentation where risk does not justify it.
Traceable
From URS to report, each evidence points to a requirement. Nothing loose, nothing orphaned.
Defensible
Dossiers structured to withstand ANVISA, FDA and EMA inspections with no improvisation.
21 control points. How many can you prove?
An independent maturity assessment covering validation, data integrity and AI governance. Eight minutes, no sign-up, results on screen — each gap linked to the standard behind it.
Where validation usually breaks
Four patterns we find in almost every diagnostic audit — and they shape how we run each project.
A dossier that won't survive inspection
Documents assembled from generic templates, with no traceability between requirement, risk and test. The finding shows up during the inspection — not before it.
Scope inflated by over-testing
Testing everything at the same intensity is expensive and does not reduce risk. Without a risk-based approach the schedule doubles, and the budget follows.
A validated state that expires quietly
Version upgrade, patch, new module: with change control disconnected from validation, the system leaves its validated state and nobody records it.
Knowledge that leaves with the consultant
A project run by a rotating junior team leaves the manufacturer dependent on the vendor, with no real knowledge transfer.
Where we operate
From pharmaceuticals and veterinary to cosmetics, food, warehousing and carriers — wherever there is a system to validate or equipment to qualify, the method and the rigour are the same.
Pharmaceutical Manufacturing
GxP systems and equipment, from the lab to distribution.
Animal Health and Veterinary
Medicines, vaccines and animal nutrition held to the same rigour.
Medical Devices
Software as a device, quality software and production equipment.
Biotechnology and Bioprocessing
Bioproduction, critical systems and high-complexity environments.
Cosmetics and Personal Care
Production, quality control and batch traceability.
Food and Supplements
Food safety, traceability and process control.
Warehousing and Distribution
Warehouses, logistics operators and distribution centres.
Transport and Cold Chain
Carriers, thermal packaging and lane qualification.
Laboratories and Clinical Research
Analytical and clinical laboratories, and research systems.
Three steps to the first deliverable
No introductory meeting, no generic proposal. You start by seeing where you stand, and only then do we discuss scope.
Assessment
Eight minutes, no sign-up. Twenty-one control points evaluated, with results on screen and the full report by email. Free, and yours even if the conversation stops here.
Scoping
Forty-five minutes on the findings from your assessment. We leave that conversation with scope, timeline and deliverables defined — not with an off-the-shelf proposal.
Delivery with evidence
Every deliverable goes through you before moving on. At the end, a dossier that sustains the validated state before any health authority.
The first project is usually small on purpose: one system, fixed scope. It is the most honest way for you to judge whether it is worth continuing.
Requirements turned into evidence
S² Compliance is the regulatory compliance brand of SS Souza & Sanchez Consultoria — a Life Sciences consultancy combining senior validation practice with proprietary automation technology.
We serve pharmaceutical, biotechnology, medical device and clinical research organisations. Our commitment: a validated state backed by evidence, defensible before any health authority — built in a fraction of the time the traditional method demands.
Proprietary technology, not spreadsheets
An in-house platform that generates and versions the lifecycle documents, with electronic execution and a chained audit trail.
One partner, full lifecycle
CSV, qualification, data integrity, audit and AI governance under a single methodology.
Multi-jurisdiction fluency
ANVISA, FDA, EMA, MHRA, PIC/S and MERCOSUR — the same evidence satisfies more than one authority without rework.
Let's talk about your validation project
Initial assessment with no commitment. Reply within 1 business day.
Video call, no commitment.